Document And Entity Information
|
6 Months Ended | |
---|---|---|
Jun. 30, 2012
|
Jul. 27, 2012
|
|
Document and Entity Information [Abstract] | ||
Entity Registrant Name | PDL BIOPHARMA, INC. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 139,931,204 | |
Amendment Flag | false | |
Entity Central Index Key | 0000882104 | |
Entity Current Reporting Status | Yes | |
Entity Voluntary Filers | No | |
Entity Filer Category | Large Accelerated Filer | |
Entity Well-known Seasoned Issuer | Yes | |
Document Period End Date | Jun. 30, 2012 | |
Document Fiscal Year Focus | 2012 | |
Document Fiscal Period Focus | Q2 |
X | ||||||||||
- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document. No definition available.
|
X | ||||||||||
- Definition
End date of current fiscal year in the format --MM-DD. No definition available.
|
X | ||||||||||
- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No definition available.
|
X | ||||||||||
- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No definition available.
|
X | ||||||||||
- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD. No definition available.
|
X | ||||||||||
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other". No definition available.
|
X | ||||||||||
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. No definition available.
|
X | ||||||||||
- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
X | ||||||||||
- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
X | ||||||||||
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. No definition available.
|
X | ||||||||||
- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. No definition available.
|
X | ||||||||||
- Details
|
Condensed Consolidated Statements Of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Revenues: | ||||
Royalties | $ 125,904 | $ 122,127 | $ 203,248 | $ 195,463 |
License and other | 10,000 | |||
Total revenues | 125,904 | 122,127 | 203,248 | 205,463 |
Operating expenses: | ||||
General and administrative | 5,145 | 3,776 | 12,090 | 9,555 |
Operating income | 120,759 | 118,351 | 191,158 | 195,908 |
Non-operating expense, net | ||||
Loss on retirement or conversion of convertible notes | (766) | (766) | ||
Interest and other income, net | 428 | 157 | 518 | 332 |
Interest expense | (7,872) | (9,780) | (16,573) | (18,934) |
Total non-operating expense, net | (7,444) | (10,389) | (16,055) | (19,368) |
Income before income taxes | 113,315 | 107,962 | 175,103 | 176,540 |
Income tax expense | 39,813 | 37,976 | 61,417 | 62,009 |
Net income | $ 73,502 | $ 69,986 | $ 113,686 | $ 114,531 |
Net income per share | ||||
Basic (in Dollars per share) | $ 0.53 | $ 0.50 | $ 0.81 | $ 0.82 |
Diluted (in Dollars per share) | $ 0.52 | $ 0.38 | $ 0.80 | $ 0.63 |
Cash dividends declared per common share (in Dollars per share) | $ 0.60 | $ 0.60 | ||
Weighted average shares outstanding | ||||
Basic (in Shares) | 139,683 | 139,650 | 139,681 | 139,645 |
Diluted (in Shares) | 142,213 | 186,060 | 142,890 | 186,055 |
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This item represents investment income derived from investments in debt and equity securities consisting of interest income earned from investments in debt securities and on cash and cash equivalents, dividend income from investments in equity securities, and income or expense derived from the amortization of investment related discounts or premiums, respectively, net of related investment expenses. This item does not include realized or unrealized gains or losses on the sale or holding of investments in debt and equity securities required to be included in earnings for the period or for other than temporary losses related to investments in debt and equity securities which are included in realized losses in the period recognized, and does not include investment income from real or personal property, such as rental income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
X | ||||||||||
- Definition
Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Condensed Consolidated Statements Of Comprehensive Income (Unaudited) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Net income | $ 73,502 | $ 69,986 | $ 113,686 | $ 114,531 |
Other comprehensive income (loss), net of tax | ||||
Unrealized gains (losses) on investments in available-for-sale securities | (16) | 71 | 13 | 47 |
Unrealized gain (losses) on cash flow hedges | 8,950 | (1,478) | 2,273 | (9,261) |
Total other comprehensive income (loss), net of tax | 8,934 | (1,407) | 2,286 | (9,214) |
Comprehensive income | $ 82,436 | $ 68,579 | $ 115,972 | $ 105,317 |
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net of tax amount of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net of tax amount, before reclassification adjustments, of the change in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Also includes an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net of tax amount of unrealized holding gain (loss) before reclassification adjustments and transfers on available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Legal settlement expense to be paid within one year of the date of the statement of financial position. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount after allocation of valuation allowances of noncurrent deferred tax asset attributable to deductible temporary differences and carryforwards. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) more than one year from the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value of the current portion of notes payable which were initially due after one year or beyond the normal operating cycle, if longer, and which are not otherwise defined in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount, net of accumulated depreciation, depletion and amortization, of long-lived physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Condensed Consolidated Balance Sheets (Parentheticals) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Preferred stock par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in Shares) | 10,000 | 10,000 |
Preferred stock, shares issued (in Shares) | 0 | 0 |
Preferred stock, shares outstanding (in Shares) | 0 | 0 |
Common stock par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in Shares) | 250,000 | 250,000 |
Common stock, shares issued (in Shares) | 139,714 | 139,680 |
Common stock, shares outstanding (in Shares) | 139,714 | 139,680 |
X | ||||||||||
- Definition
Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The net change during the reporting period in accrued legal settlement expense. No definition available.
|
X | ||||||||||
- Definition
Purchase Of Call Options to reduce the potential dilution upon conversion of convertible notes. No definition available.
|
X | ||||||||||
- Definition
Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net amount of deferred income taxes and income tax credits less the tax benefit from exercise of stock options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of excess tax benefit (tax deficiency) that arises when compensation cost from non-qualified share-based compensation recognized on the entity's tax return exceeds (is less than) compensation cost from equity-based compensation recognized in financial statements. Excess tax benefit (tax deficiency) increases (decreases) net cash provided by financing activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of excess tax benefit (tax deficiency) that arises when compensation cost from non-qualified equity-based compensation recognized on the entity's tax return exceeds (is less than) compensation cost from equity-based compensation recognized in financial statements. Excess tax benefit (tax deficiency) reduces (increases) net cash provided by operating activities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease) during the reporting period in other noncurrent operating liabilities not separately disclosed in the statement of cash flows. No definition available.
|
X | ||||||||||
- Definition
The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of cash paid for interest during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net cash inflow or outflow from financing activity for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net cash inflow or outflow from investing activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash inflow associated with maturities (principal being due), prepayments and calls (requests of early payments) on securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
Note 1 - Summary of Significant Accounting Policies
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Presentation and Significant Accounting Policies [Text Block] |
Basis
of Presentation
The
accompanying unaudited Condensed Consolidated Financial
Statements have been prepared in accordance with U.S.
generally accepted accounting principles (GAAP) for interim
financial information. The financial statements include all
adjustments (consisting only of normal recurring
adjustments) the management of PDL BioPharma, Inc. (the
Company, PDL, we, us or our) believes are necessary for a
fair presentation of the periods presented. These interim
financial results are not necessarily indicative of results
expected for the full fiscal year or for any subsequent
interim period.
The
accompanying Condensed Consolidated Financial Statements
and related financial information should be read in
conjunction with the audited Consolidated Financial
Statements and the related notes thereto for the year ended
December 31, 2011, included in our Annual Report on
Form 10-K filed with the U.S. Securities and Exchange
Commission. The Condensed Consolidated Balance Sheet at
December 31, 2011, has been derived from the audited
Consolidated Financial Statements at that date.
Principles
of Consolidation
The
Consolidated Financial Statements include the accounts of
PDL and its wholly-owned subsidiaries. All material
intercompany balances and transactions have been eliminated
in consolidation.
Customer
Concentration
The
percentage of total revenue earned from our
licensees’ net product sales, which individually
accounted for 10% or more of our total revenues,
was:
Foreign
Currency Hedging
We
hedge certain Euro-denominated currency exposures related
to our licensees’ product sales with Euro forward
contracts. In general, these contracts are intended to
offset the underlying Euro market risk in our royalty
revenues. We do not enter into speculative foreign currency
transactions. We have designated the Euro forward contracts
as cash flow hedges.
At the inception of the hedging
relationship and on a quarterly basis, we assess hedge
effectiveness. The fair value of the Euro forward contracts
is estimated using pricing models with readily observable
inputs from actively quoted markets and is disclosed on a
gross basis. The aggregate unrealized gain or loss, net of
tax, on the effective portion of the hedge is recorded in
stockholders’ deficit as accumulated other
comprehensive income (loss). Gains or losses on cash flow
hedges are recognized as an adjustment to royalty revenue
in the same period that the hedged transaction impacts
earnings as royalty revenue. In January 2012, we
modified our existing Euro forward and option contracts
related to our licensees’ sales through December 2012
into Euro forward contracts with more favorable
rates. Ineffectiveness, if any, resulting
from either the modified 2012 hedge or lower than
forecasted Euro-based royalties is reclassified from other
comprehensive income (loss) and recorded as interest and
other income, net, in the period it occurs.
Comprehensive
Income
In
the first quarter of 2012, we adopted Financial Accounting
Standards Board (FASB) accounting standard update (ASU)
2011-05, and have presented the components of other
comprehensive income (loss) in the Condensed Consolidated
Statements of Comprehensive Income. Also in accordance with
this ASU, we have applied this guidance retrospectively to
all periods presented. The adoption of the guidance was a
change to the presentation of other comprehensive income
(loss) and had no effect on our condensed consolidated
financial statements. See Note 14 for our discussion of
accumulated other comprehensive income (loss).
Recent
Accounting Pronouncements
In
December 2011, the FASB issued ASU 2011-11 that requires
new disclosures associated with offsetting financial
instruments and derivative instruments on the balance sheet
that will enable users to evaluate the effect on an
entity’s financial position. The ASU will be
effective for our first quarter of 2013, but is not
expected to have a material impact on our financial
statements.
|
X | ||||||||||
- Definition
The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity. No definition available.
|
Note 2 - Net Income per Share
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Text Block] |
2.
Net Income per Share
We
compute net income per basic share using the
weighted-average number of shares of common stock
outstanding during the period less the weighted-average
number of restricted stock shares that are subject to
repurchase.
We
compute net income per diluted share using the sum of the
weighted-average number of common and common equivalent
shares outstanding. Common equivalent shares used in the
computation of net income per diluted share include shares
that may be issued under our stock options and restricted
stock awards, our 2.875% Convertible Senior Notes due
February 15, 2015 (February 2015 Notes), our 2.875%
Series 2012 Convertible Notes due February 15, 2015 (Series
2012 Notes), our 3.75% Senior Convertible Notes due May 1,
2015 (May 2015 Notes) and, in 2011, our 2.00% Convertible
Senior Notes due February 15, 2012 (2012 Notes), on a
weighted average basis for the period that the notes were
outstanding, including the effect of adding back interest
expense, net of tax, and the underlying shares using the
if-converted method. Our 2012 Notes were fully retired as
of June 30, 2011, and $179.0 million aggregate principal
amount of our February 2015 Notes was exchanged for our
Series 2012 Notes in the first quarter of 2012.
The
Series 2012 Notes are net share settled, with the principal
amount settled in cash and the excess settled in our common
stock. The weighted-average share adjustment related to our
Series 2012 Notes includes the shares issuable in respect
of such excess.
We
excluded 22.1 million and 20.0 million shares of potential
dilution for the May 2015 Notes and 18.8 million and 17.0
million shares of potential dilution for our warrants for
the six months ended June 30, 2012 and 2011, respectively,
because the conversion price of the Notes and exercise
price of the warrants exceeded the average market price of
our common stock and thus, for the periods presented, no
stock was issuable upon conversion. These securities could
be dilutive in future periods. In addition, we excluded
22.1 million and 20.0 million shares for our purchased call
options for the six months ended June 30, 2012 and 2011,
respectively because they will always be anti-dilutive
and therefore, will have no effect on diluted net income
per share. For further information related to our
convertible notes, see Note 9.
We
excluded 0.2 million shares underlying outstanding stock
options, calculated on a weighted average, from our net
income per diluted share calculations for each of the three
and six months ended June 30, 2012 and June 30, 2011,
because their effect was anti-dilutive.
|
X | ||||||||||
- Definition
The entire disclosure for earnings per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 3 - Fair Value Measurements
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Text Block] |
3. Fair Value
Measurements
The
fair value of our financial instruments are estimates of
the amounts that would be received if we were to sell an
asset or we paid to transfer a liability in an orderly
transaction between market participants at the measurement
date or exit price. The assets and liabilities are
categorized and disclosed in one of the following three
categories:
Level
1 – based on quoted market prices in active markets
for identical assets and liabilities;
Level
2 – based on quoted market prices for similar assets
and liabilities, using observable market based inputs or
unobservable market based inputs corroborated by market
data; and
Level
3 – based on unobservable inputs using
management’s best estimate and assumptions when
inputs are unavailable. As of June 30, 2012, and December
31, 2011, we had no Level 3 assets or liabilities.
Corporate
debt securities consist primarily of U.S. Corporate bonds.
The fair value of corporate debt securities is estimated
using recently executed transactions or market quoted
prices, where observable. Independent pricing sources are
also used for valuation.
The
fair value of commercial paper is estimated based on
observable inputs of the comparable securities.
The
fair value of the foreign currency hedging contracts is
estimated based on pricing models using readily observable
inputs from actively quoted markets and is disclosed
on a gross basis.
The
fair value of our note receivable was determined using
discounted cash flows incorporating expected payments and
the interest rate extended on the note.
The
fair value of our convertible notes and our Non-recourse
Notes, as defined herein, was based on quoted market
pricing or dealer quotes of our then outstanding
notes.
|
X | ||||||||||
- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 4 - Cash Equivalents, Short-term and Long-term Investments
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash, Cash Equivalents, and Marketable Securities [Text Block] |
4.
Cash Equivalents and Investments
As
of June 30, 2012, and December 31, 2011, we had
invested our excess cash balances primarily in money market
funds, corporate debt securities, commercial paper, U.S.
government sponsored agency bonds and U.S. treasury
securities. Our securities are classified as
available-for-sale and are carried at estimated fair value,
with unrealized gains and losses, net of estimated taxes,
reported in accumulated other comprehensive income (loss)
in stockholders’ deficit. See Note 3 for fair value
measurement information. The cost of securities sold is
based on the specific identification method. To date, we
have not experienced credit losses on investments in these
instruments and we do not require collateral for our
investment activities.
We
did not recognize any gains or losses on sales of
available-for-sale securities for the three and six months
ended June 30, 2012 and 2011. The net unrealized gain on
investments included in other comprehensive income, net of
tax, was approximately $42,000 as of June 30, 2012. No
significant facts or circumstances have arisen to indicate
that there has been any deterioration in the
creditworthiness of the issuers of these securities. Based
on our review of these securities, we believe we had no
other-than-temporary impairments on these securities as of
June 30, 2012. Our 2012 investments in a loss position at
June 30, 2012, reflected unrealized losses of less than
$1,000, net of tax.
|
X | ||||||||||
- Definition
The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss). No definition available.
|
Note 5 - Foreign Currency Hedging
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Text Block] |
5.
Foreign Currency Hedging
In
January 2012, we modified our existing Euro forward and
option contracts related to our licensees’ sales
through December 2012 into Euro forward contracts with more
favorable rates. Additionally, we entered into a series of
Euro forward contracts covering the quarters in which our
licensees’ sales occur through December 2013.
The
foreign currency exchange contracts used to hedge royalty
revenues based on underlying Euro-denominated sales are
designated as cash flow hedges. Euro forward contracts are
presented on a net basis on our Condensed Consolidated
Balance Sheets as we have entered into a netting
arrangement with the counterparty.
The
notional amounts, Euro exchange rates, fair values of our
Euro forward contracts at June 30, 2012, and Euro forward
and option contracts at December 31, 2011, designated as
cash flow hedges were:
Euro Forward
Contracts
The
location and fair values of our Euro contracts in our
Condensed Consolidated Balance Sheets were:
The
effect of derivative instruments designated as cash flow
hedges in our Condensed Consolidated Statements of Income
and our Condensed Consolidated Statements of Comprehensive
Income were:
(1)
Net change in the fair value of the effective portion of
cash flow hedges classified in other comprehensive income
(loss) (OCI)
(2)
Effective portion classified as royalty revenue
(3)
Ineffective portion classified as interest and other
income, net
For the three months ended June
30, 2012, we recognized a gain of approximately $57,000
associated with the ineffectiveness of the modified 2012
foreign exchange hedge. For the six months ended June 30,
2012, we recognized a loss, of approximately $27,000
associated with the ineffectiveness of the modified 2012
foreign exchange hedge. There was no ineffectiveness
related to forecasted transactions for the three and six
months ended June 30, 2012, and there was approximately
$19,000 of ineffectiveness related to lower than forecasted
Euro-based royalty transactions for the three and six
months ended June 30, 2011. Approximately $0.8
million is expected to be reclassified from other
comprehensive income (loss) against earnings in the next 12
months.
|
X | ||||||||||
- Definition
The entire disclosure for the entity's entire derivative instruments and hedging activities. Describes an entity's risk management strategies, derivatives in hedging activities and non-hedging derivative instruments, the assets, obligations, liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 6 - Note Receivable
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] |
6.
Note Receivable
In
March 2012, the Company executed a $7.5 million two-year
senior secured note receivable. In addition to interest,
the note gives PDL certain rights to negotiate for certain
royalty assets. The note was recorded net of origination
fees that are accreted to the note receivable as interest
income using the interest method. The note bears interest
at 10% per annum, with interest due semi-annually and final
interest due at maturity together with the principal. The
Company has not assigned a risk grade to the receivable or
recorded an allowance for credit loss as PDL anticipates
all payments will be received in full when due. No
impairment has been recorded as the payments on the note
are current. For fair value information related to our note
receivable, see Note 3.
|
X | ||||||||||
- Definition
The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 7 - Accrued Liabilities
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable and Accrued Liabilities Disclosure [Text Block] |
7.
Accrued Liabilities
|
X | ||||||||||
- Definition
The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 8 - Commitments and Contingencies
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Commitments and Contingencies Disclosure [Text Block] |
8.
Commitments and Contingencies
Legal
Proceedings
Communications
with Genentech regarding European SPCs
In
August 2010, we received a letter from Genentech, sent on
behalf of F. Hoffmann-LaRoche Ltd. (Roche) and Novartis AG
(Novartis), asserting that Avastin, Herceptin, Lucentis and
Xolair®
(the Genentech Products) do not infringe the supplementary
protection certificates (SPCs) granted to PDL by various
countries in Europe for each of the Genentech Products and
seeking a response from PDL to these assertions. Genentech
did not state what actions, if any, it intends to take with
respect to its assertions. PDL’s SPCs were granted by
the relevant national patent offices in Europe and
specifically cover the Genentech Products. The SPCs
covering the Genentech Products effectively extend our
European patent protection for the ‘216B Patent
generally until December 2014, except that the SPCs for
Herceptin will generally expire in July 2014.
Genentech’s
letter does not suggest that the Genentech Products do not
infringe PDL’s U.S. patents to the extent that such
Genentech Products are made, used or sold in the United
States (U.S.-based Sales). Genentech’s quarterly
royalty payments received after receipt of the letter
included royalties generated on all worldwide sales of the
Genentech Products.
If
Genentech is successful in asserting this position, then
under the terms of our license agreements with Genentech,
it would not owe us royalties on sales of the Genentech
Products that are both manufactured and sold outside of the
United States. Royalties on sale of the Genentech Products
that are made and sold outside of the United States
(ex-U.S.-based Manufacturing and Sales) accounted for
approximately 32% of our royalty revenues for the six
months ended June 30, 2012. Based on announcements by Roche
regarding moving more manufacturing outside of the United
States, we expect this amount to increase in the
future.
We
believe that the SPCs are enforceable against the Genentech
Products, that Genentech’s letter violates the terms
of the 2003 settlement agreement and that Genentech owes us
royalties on sales of the Genentech Products on a worldwide
basis. We intend to vigorously assert our SPC-based patent
rights.
Nevada
Litigation with Genentech, Roche and Novartis in Nevada
State Court
In
August 2010, we filed a complaint in the Second Judicial
District of Nevada, Washoe County, naming Genentech, Roche
and Novartis as defendants. We intend to enforce our rights
under our 2003 settlement agreement with Genentech and are
seeking an order from the court declaring that Genentech is
obligated to pay royalties to us on ex-U.S.-based
Manufacturing and Sales of the Genentech Products.
The
2003 settlement agreement was entered into as part of a
definitive agreement resolving intellectual property
disputes between the two companies at that time. The
agreement limits Genentech’s ability to challenge
infringement of our patent rights and waives
Genentech’s right to challenge the validity of our
patent rights. Certain breaches of the 2003 settlement
agreement as alleged by our complaint require Genentech to
pay us liquidated and other damages of potentially greater
than one billion dollars. This amount includes a
retroactive royalty rate of 3.75% on past U.S.-based Sales
of the Genentech Products and interest, among other items.
We may also be entitled to either terminate our license
agreements with Genentech or be paid a flat royalty of
3.75% on future U.S.-based Sales of the Genentech
Products.
In
November 2010, Genentech and Roche filed a motion to
dismiss our complaint against them in which we seek to
enforce our rights under the 2003 settlement agreement with
Genentech. Genentech and Roche's motions to dismiss under
Nevada Rule of Civil Procedure 12(b)(5) alleged that all of
our claims for relief relating to the 2003 settlement
agreement should be dismissed because the 2003 settlement
agreement applies only to our U.S. patents. In addition,
Roche filed a separate motion to dismiss our complaint
under Nevada Rule of Civil Procedure 12(b)(2) on the ground
that the Nevada court lacks personal jurisdiction over
Roche. On July 7, 2011, the Second Judicial District Court
of Nevada ruled in favor of us on the two motions to
dismiss filed by Genentech and Roche. The court denied
Genentech and Roche's motion to dismiss four of our five
claims for relief and, further, denied Roche's separate
motion to dismiss for lack of personal jurisdiction. The
court dismissed one of our claims that Genentech committed
a bad-faith breach of the covenant of good faith and fair
dealing stating that, based on the current state of the
pleadings, no "special relationship" had been established
between Genentech and us as required under Nevada law. On
November 1, 2011, the Nevada court issued an order
accepting Roche’s stipulation of waiver to its
personal jurisdiction defense. As a result of the order,
Roche is foreclosed from reliance on lack of personal
jurisdiction in defending against our claims.
On
February 25, 2011, we reached a settlement with
Novartis under which, among other things, we agreed to
dismiss our claims against Novartis in the action in Nevada
state court against Genentech, Roche and Novartis.
Genentech and Roche continue to be parties to the Nevada
suit.
The
court has scheduled trial to commence on October 7, 2013.
The outcome of this litigation is uncertain and we may not
be successful in our allegations.
Lease
Guarantee
In
connection with the spin-off of Facet Biotech Corporation
(Facet) in 2008, we entered into amendments to the leases
for our former facilities in Redwood City, California,
under which Facet was added as a co-tenant under the
leases, and a Co-Tenancy Agreement, under which Facet
agreed to indemnify us for all matters related to the
leases attributable to the period after the spin-off date.
Should Facet default under its lease obligations, we would
be held liable by the landlord as a co-tenant and, thus, we
have in substance guaranteed the payments under the lease
agreements for the Redwood City facilities. As of June 30,
2012, the total lease payments for the duration of the
guarantee, which runs through December 2021, are
approximately $105.6 million. We would also be responsible
for lease-related costs including utilities, property taxes
and common area maintenance which may be as much as the
actual lease payments if Facet were to default. In April
2010, Abbott Laboratories acquired Facet and later renamed
the company Abbott Biotherapeutics Corp.
As
of June 30, 2012, and December 31, 2011, we had a
liability of $10.7 million on our Condensed Consolidated
Balance Sheets for the estimated fair value of this
guarantee. In future periods, we may increase the recorded
liability for this obligation if we conclude that a loss,
which is larger than the amount recorded, is both probable
and estimable.
|
X | ||||||||||
- Definition
The entire disclosure for commitments and contingencies. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Debt [Text Block] |
9.
Convertible Notes and Non-recourse Notes
(1)
Anticipated repayment date
As
of June 30, 2012, PDL was in compliance with all applicable
debt covenants, and embedded features of all debt
agreements were evaluated and did not need to be accounted
for separately. For fair value information on our
convertible notes and Non-recourse Notes, see Note
3.
Series
2012 Notes
In
January 2012, we exchanged $169.0 million aggregate
principal of our February 2015 Notes for an identical
principal amount of new Series 2012 Notes, plus a cash
payment of $5.00 for each $1,000 principal amount tendered
for a total cash incentive payment of approximately
$845,000. The cash incentive payment was allocated to
deferred issue costs of $765,000, additional paid-in
capital of $52,000 and deferred tax assets of $28,000. The
deferred issue costs will be recognized over the life of
the Series 2012 Notes as interest expense. In February
2012, we entered into separate privately negotiated
exchange agreements under which we exchanged $10.0 million
aggregate principal amount of our February 2015 Notes for
an identical principal amount of our Series 2012
Notes.
The
terms of the Series 2012 Notes are governed by the
indenture dated as of January 5, 2012 (Indenture) and
include a net share settlement feature, meaning that if a
conversion occurs, the principal amount will be settled in
cash and the excess, if any, will be settled in the
Company’s common stock. The Series 2012 Notes may not
be redeemed by the Company prior to their stated maturity
date. Our Series 2012 Notes are due February 15, 2015 and
bear interest at a rate of 2.875% per annum, payable
semiannually in arrears on February 15 and August 15 of
each year. This is the same interest rate that we paid on
the February 2015 Notes.
The
initial conversion rate of the Series 2012 Notes was
155.396 shares of common stock per $1,000 principal amount,
or approximately $6.44 per common share, subject to further
adjustment upon certain events including dividend payments.
Third party transaction costs of approximately $813,000
related to the exchange transactions have been recognized
within general and administrative expense, of which
$216,000 was recognized in the first quarter of 2012 and
$597,000 was recognized during the year ended December 31,
2011.
Holders
may convert their Series 2012 Notes at any time prior to
the close of business on the second scheduled trading day
immediately preceding the stated maturity date of the
Series 2012 Notes under the following circumstances:
Holders
of our Series 2012 Notes who convert their Series 2012
Notes in connection with a fundamental change resulting in
the reclassification, conversion, exchange or cancellation
of our common stock may be entitled to a make-whole premium
in the form of an increase in the conversion rate. Such
fundamental change is generally defined to include a merger
involving PDL, an acquisition of a majority of PDL’s
outstanding common stock and a change of a majority of
PDL’s board of directors without the approval of the
board of directors.
We
allocated $2.3 million of the remaining deferred February
2015 Notes original issue discount as of the date of the
exchange to the Series 2012 Notes based on the percentage
of the February 2015 Notes exchanged. In accordance with
the accounting guidance for convertible debt instruments
that may be settled in cash or other assets on conversion,
we were required to separately account for the liability
component of the instrument in a manner that reflects the
market interest rate for a similar nonconvertible
instrument at the date of issuance. As a result, we
separated the principal balance of the Series 2012 Notes,
net of the allocated original issue discount, between the
fair value of the debt component and the common stock
conversion feature. Using an assumed borrowing rate of
7.3%, which represents the estimated market interest rate
for a similar nonconvertible instrument available to us
during the period of the exchange transactions, we recorded
a total debt discount of $16.8 million, allocated $10.9
million to additional paid-in capital and $5.9 million to
deferred tax liability. The discount is being amortized to
interest expense over the term of the Series 2012 Notes and
increases interest expense during the term of the Series
2012 Notes from the 2.875% cash coupon interest rate to an
effective interest rate of 7.3%. The common stock
conversion feature is recorded as a component of
stockholders’ deficit.
The
principal amount, carrying value and unamortized discount
of our Series 2012 Notes were:
Interest
expense for our Series 2012 Notes on the Condensed
Consolidated Statements of Income was:
As
of June 30, 2012, our Series 2012 Notes are convertible
into 162.885 shares of the Company’s common stock per
$1,000 of principal amount, or approximately $6.14 per
common share, subject to further adjustment upon certain
events including dividend payments. As of June 30, 2012,
the remaining discount amortization period was 2.6
years.
Our
common stock price did not exceed the conversion threshold
price of $8.17 per common share for at least 20 days during
the 30 consecutive trading days ended March 31, 2012;
accordingly the Series 2012 Notes were not convertible at
the option of the holder during the quarter ended June 30,
2012. Our common stock did not exceed the conversion
threshold price of $7.98 for at least 20 days during 30
consecutive trading days ended June 30, 2012; accordingly
the Series 2012 Notes are not convertible at the option of
the holder during the quarter ended September 30, 2012. At
June 30, 2012, the if-converted value of our Series 2012
Notes exceeded their principal amount by approximately
$14.3 million.
May
2015 Notes
As
of June 30, 2012, our May 2015 Notes are convertible into
142.5217 shares of the Company’s common stock per
$1,000 of principal amount, or approximately $7.02 per
common share, subject to further adjustment upon certain
events including dividend payments. If a conversion occurs,
to the extent that the conversion value exceeds the
principal amount, the principal amount is due in cash and
the difference between the conversion value and the
principal amount is due in shares of the Company’s
common stock. As of June 30, 2012, the remaining discount
amortization period was 2.8 years.
The
principal amount, carrying value and unamortized discount
of our May 2015 Notes were:
Interest
expense for our May 2015 Notes on the Condensed
Consolidated Statements of Income was:
As
of June 30, 2012, the market price condition for
convertibility of our May 2015 Notes was not met and there
were no related purchased call options or warrants
exercised.
Purchased
Call Options
At
June 30, 2012, the purchased call options cover, subject to
anti-dilution and certain other customary adjustments
substantially similar to those in our May 2015 Notes,
approximately 22.1 million shares of our common stock at a
strike price of approximately $7.02, which corresponds to
the conversion price of our May 2015 Notes. We may exercise
the purchased call options upon conversion of our May 2015
Notes and require the hedge counterparty to deliver shares
to the Company in an amount equal to the shares required to
be delivered by the Company to the note holder for the
excess conversion value.
Warrants
At
June 30, 2012, the outstanding warrants of up to 27.5
million shares of common stock underlying our May 2015
Notes, have a current strike price of approximately $8.25
per share, subject to additional anti-dilution and certain
other customary adjustments.
February
2015 Notes
As
of June 30, 2012, our February 2015 Notes aggregate
principal amount outstanding was $1.0 million, and were
convertible into 162.885 shares of common stock per $1,000
principal amount or approximately $6.14 per common share.
As of June 30, 2012, the remaining unamortized issuance
costs of approximately $15,000 and the unamortized discount
of approximately $11,000 are being amortized to interest
expense over the term of our February 2015 Notes, with a
remaining amortization period of approximately 2.6
years.
2012
Notes Retirement
Our
2012 Notes of $133.5 million aggregate principal were fully
retired at June 30, 2011, at a redemption price of 100.29%
of principal for aggregate consideration of $133.9 million
plus interest of $1.0 million. We recorded a net loss of
$0.8 million from the redemption of the debt in the second
quarter of 2011.
Non-recourse
Notes
As
of June 30, 2012, the remaining principal balance of our
Non-recourse Notes was $22.7 million. The remaining related
unamortized issuance costs of $0.1 million were
included as a component of Prepaid and other current assets
on the Condensed Consolidated Balance Sheets. These
issuance costs are being amortized to interest expense
using the effective interest method with approximately 0.3
years remaining.
|
X | ||||||||||
- Definition
The entire disclosure for long-term debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 10 - Other Long-Term Liabilities
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities Disclosure [Text Block] |
10.
Other Long-Term Liabilities
Other
long-term liabilities consisted of the following:
|
X | ||||||||||
- Definition
The entire disclosure for other liabilities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 11 - Stock-Based Compensation
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
11.
Stock-Based Compensation
The
Company issued approximately 59,000 shares of restricted
stock in the first quarter of 2012 that will vest in
December 2013, and approximately 56,000 shares of
restricted stock in the second quarter of 2012, of which
32,000 will vest in June 2013 and 24,000 will vest in
December 2013. The Company issued approximately 115,000
shares of restricted stock in the second quarter of 2011,
of which, approximately 18,000 shares were forfeited in
December 2011, 34,000 shares vested in June 2012 and the
remaining 63,000 shares will vest in December 2012.
Additionally,
the Company issued non-employees restricted stock in the
second half of 2011, which vest both over time and upon the
achievement of certain performance goals.
|
X | ||||||||||
- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 12 - Cash Dividends
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note Disclosure [Text Block] |
12.
Cash Dividends
On
January 18, 2012, our board of directors declared that
the regular quarterly dividends to be paid to our
stockholders in 2012 will be $0.15 per share of
common stock, payable on March 14,
June 14, September 14 and December 14
of 2012 to stockholders of record on March 7,
June 7, September 7 and December 7 of 2012,
the record dates for each of the dividend payments,
respectively.
In
connection with the June 14, 2012, dividend payment, the
conversion rates for our convertible notes adjusted as
follows:
|
X | ||||||||||
- Definition
The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 13 - Income Taxes
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Text Block] |
13.
Income Taxes
For
the three and six months ended June 30, 2012 and 2011,
income tax expense was primarily derived by applying the
federal statutory rate of 35% to operating income before
income taxes.
In
general, our income tax returns are subject to examination
by tax authorities for tax years 1995 forward. In
May 2012, PDL received a “no-change” letter
from the Internal Revenue Service (IRS) upon completion of
an examination of the Company’s 2008 Federal tax
return. The California Franchise Tax Board (FTB) is
currently examining the Company’s 2008 and 2009 tax
returns. Although the timing of the resolution of income
tax examinations is highly uncertain, and the amounts
ultimately paid, if any, upon resolution of the issues
raised by the taxing authorities may differ materially from
the amounts accrued for each year, we do not anticipate any
material change to the amount of our unrecognized tax
benefits over the next 12 months.
|
X | ||||||||||
- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 14 - Accumulated Comprehensive Loss
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comprehensive Income (Loss) Note [Text Block] |
14.
Accumulated Other Comprehensive Income (Loss)
Comprehensive
income is comprised of net income and other comprehensive
income (loss). We include unrealized net gains on
investments held in our available-for-sale securities and
unrealized gains (losses) on our cash flow hedges in other
comprehensive income (loss), and present the amounts net of
tax. Our other comprehensive income (loss) is included in
our Condensed Consolidated Statements of Comprehensive
Income.
The
balance of accumulated other comprehensive income (loss),
net of tax, was as follows:
|
X | ||||||||||
- Definition
The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 15. Subsequent Event
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Subsequent Events [Text Block] |
15.
Subsequent Event
In
July 2012, PDL loaned $35 million to Merus Labs
International, Inc. (Merus Labs) in connection with its
acquisition of a commercial-stage pharmaceutical product and
related assets (the Assets). In addition, PDL agreed to
provide a $20 million letter of credit on behalf of Merus
Labs that the seller of the Assets may draw upon to satisfy
the remaining $20 million purchase price obligation on July
11, 2013 (Letter of Credit). Draws on the Letter of Credit
will be funded from the proceeds of an additional loan to
Merus Labs. Outstanding borrowings under the July 2012 loan
bear interest at the rate of 13.5% per annum and outstanding
borrowings as a result of draws on the Letter of Credit bear
interest at the rate of 14.0% per annum. Merus Labs is
required to make four periodic principal payments in respect
of the July 2012 loan, with repayment of the remaining
principal balance of all loans due on March 31, 2015. The
borrowings are subject to mandatory prepayments upon certain
asset dispositions or debt issuances upon the terms set forth
in the credit agreement (Credit Agreement).
The
Credit Agreement provides for a number of standard events
of default, including payment, bankruptcy, covenant,
judgment and cross-defaults.
|
X | ||||||||||
- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. No definition available.
|
Accounting Policies, by Policy (Policies)
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Basis of Accounting [Text Block] | Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information. The financial statements include all adjustments (consisting only of normal recurring adjustments) the management of PDL BioPharma, Inc. (the Company, PDL, we, us or our) believes are necessary for a fair presentation of the periods presented. These interim financial results are not necessarily indicative of results expected for the full fiscal year or for any subsequent interim period. The accompanying Condensed Consolidated Financial Statements and related financial information should be read in conjunction with the audited Consolidated Financial Statements and the related notes thereto for the year ended December31, 2011, included in our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. The Condensed Consolidated Balance Sheet at December31, 2011, has been derived from the audited Consolidated Financial Statements at that date. |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation The Consolidated Financial Statements include the accounts of PDL and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | Foreign Currency Hedging We hedge certain Euro-denominated currency exposures related to our licensees' product sales with Euro forward contracts. In general, these contracts are intended to offset the underlying Euro market risk in our royalty revenues. We do not enter into speculative foreign currency transactions. We have designated the Euro forward contracts as cash flow hedges. At the inception of the hedging relationship and on a quarterly basis, we assess hedge effectiveness. The fair value of the Euro forward contracts is estimated using pricing models with readily observable inputs from actively quoted markets and is disclosed on a gross basis. The aggregate unrealized gain or loss, net of tax, on the effective portion of the hedge is recorded in stockholders' deficit as accumulated other comprehensive income (loss). Gains or losses on cash flow hedges are recognized as an adjustment to royalty revenue in the same period that the hedged transaction impacts earnings as royalty revenue. In January 2012, we modified our existing Euro forward and option contracts related to our licensees' sales through December 2012 into Euro forward contracts with more favorable rates. Ineffectiveness, if any, resulting from either the modified 2012 hedge or lower than forecasted Euro-based royalties is reclassified from other comprehensive income (loss) and recorded as interest and other income, net, in the period it occurs. |
Comprehensive Income, Policy [Policy Text Block] | Comprehensive Income In the first quarter of 2012, we adopted Financial Accounting Standards Board (FASB) accounting standard update (ASU) 2011-05, and have presented the components of other comprehensive income (loss) in the Condensed Consolidated Statements of Comprehensive Income. Also in accordance with this ASU, we have applied this guidance retrospectively to all periods presented. The adoption of the guidance was a change to the presentation of other comprehensive income (loss) and had no effect on our condensed consolidated financial statements. See Note 14 for our discussion of accumulated other comprehensive income (loss). |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements In December 2011, the FASB issued ASU 2011-11 that requires new disclosures associated with offsetting financial instruments and derivative instruments on the balance sheet that will enable users to evaluate the effect on an entity's financial position. The ASU will be effective for our first quarter of 2013, but is not expected to have a material impact on our financial statements. |
X | ||||||||||
- Definition
The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). No definition available.
|
X | ||||||||||
- Definition
Disclosure of accounting policy for comprehensive income. No definition available.
|
X | ||||||||||
- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Disclosure of the adoption of new accounting pronouncements that may impact the entity's financial reporting. No definition available.
|
X | ||||||||||
- Definition
Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. No definition available.
|
Note 2 - Net Income per Share (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the numerators and the denominators of the basic and diluted per-share (or per-unit) computations for income from continuing operations, including the effect that has been given to preferred dividends. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 3 - Fair Value Measurements (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Liabilities Not Recorded At Fair Value [Table Text Block] |
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 4 - Cash Equivalents, Short-term and Long-term Investments (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, by Balance Sheet Grouping [Table Text Block] |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments Classified by Contractual Maturity Date [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. No definition available.
|
X | ||||||||||
- Definition
Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. No definition available.
|
Note 5 - Foreign Currency Hedging (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 7 - Accrued Liabilities (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accrued Liabilities [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the components of accrued liabilities. No definition available.
|
Note 9 - Convertible Notes and Non-recourse Notes (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Debt [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series 2012 Notes [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Interest Expense On Series 2012 Notes [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
X | ||||||||||
- Definition
Tabular disclosure of notes including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Tabular disclosure of notes including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer. No definition available.
|
X | ||||||||||
- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation. No definition available.
|
Note 10 - Other Long-Term Liabilities (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Assets and Other Liabilities [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of other assets and other liabilities not separately disclosed on the balance sheet. No definition available.
|
Note 11 - Stock-Based Compensation (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 12 - Cash Dividends (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||
Schedule of Conversion Rates for Convertible Notes [Table Text Block] |
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
Note 13 - Income Taxes (Tables)
|
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 14 - Accumulated Comprehensive Loss (Tables)
|
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] |
|
X | ||||||||||
- Definition
Tabular disclosure of the components of accumulated other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 1 - Summary of Significant Accounting Policies (Detail)
|
Jun. 30, 2012
|
---|---|
Minimum threshold percent of total royalty income requiring disclosure by licensee by product name | 10.00% |
X | ||||||||||
- Definition
Minimum threshold percent of total royalty income requiring disclosure by licensee by product name. No definition available.
|
Note 1 - Summary of Significant Accounting Policies (Detail) - Percentage of Total Revenue From Licenses Over 10% of Revenue
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Genentech [Member] | Avastin [Member]
|
||||
Licensee | 33.00% | 34.00% | 32.00% | 31.00% |
Genentech [Member] | Herceptin [Member]
|
||||
Licensee | 35.00% | 35.00% | 35.00% | 33.00% |
Genentech [Member] | Lucentis [Member]
|
||||
Licensee | 22.00% | 20.00% | 19.00% | 16.00% |
Elan [Member] | Tysabri [Member]
|
||||
Licensee | 10.00% | 9.00% | 12.00% | 10.00% |
X | ||||||||||
- Definition
Percentage of revenue generated from a single external customer that accounts for 10 percent or more of an entity's revenues. No definition available.
|
Note 2 - Net Income per Share (Detail) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Series 2012 Notes [Member]
|
||||
Debt Instrument, Interest Rate, Stated Percentage | 2.875% | 2.875% | ||
Convertible Notes Payable (in Dollars) | $ 179.0 | $ 179.0 | ||
Convertible May 2015 Notes [Member]
|
||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 22.1 | 20.0 | ||
Warrant [Member]
|
||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 18.8 | 17.0 | ||
Purchased Call Options [Member]
|
||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 22.1 | 20.0 | ||
Stock Options [Member]
|
||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 0.2 | 0.2 | 0.2 | 0.2 |
Due February 2015 [Member]
|
||||
Debt Instrument, Interest Rate, Stated Percentage | 2.875% | 2.875% | ||
Series 2012 Notes [Member]
|
||||
Debt Instrument, Interest Rate, Stated Percentage | 2.875% | 2.875% | ||
Convertible May 2015 Notes [Member]
|
||||
Debt Instrument, Interest Rate, Stated Percentage | 3.75% | 3.75% | ||
Due 2012 [Member]
|
||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | 2.00% |
X | ||||||||||
- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Interest rate stated in the contractual debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 2 - Net Income per Share (Detail) - Net Income Per Basic and Diluted Share (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Numerator | ||||
Net income used to compute net income per basic share (in Dollars) | $ 73,502 | $ 69,986 | $ 113,686 | $ 114,531 |
Add back interest expense for convertible notes, net of estimated tax of $3,000 and $0.7 million for the three months ended June 30, 2012 and 2011, respectively and $18,000 and $1.4 million for the six months ended June 30, 2012 and 2011, respectively (see Note 9) (in Dollars) | 6 | 1,275 | 33 | 2,549 |
Income used to compute net income per diluted share (in Dollars) | $ 73,508 | $ 71,261 | $ 113,719 | $ 117,080 |
Denominator | ||||
Total weighted-average shares used to compute net income per basic share | 139,683 | 139,650 | 139,681 | 139,645 |
Weighted-average shares used to compute net income per diluted share | 142,213 | 186,060 | 142,890 | 186,055 |
Net income per basic share (in Dollars per share) | $ 0.53 | $ 0.50 | $ 0.81 | $ 0.82 |
Net income per diluted share (in Dollars per share) | $ 0.52 | $ 0.38 | $ 0.80 | $ 0.63 |
Restricted Stock [Member]
|
||||
Denominator | ||||
Restricted stock outstanding | 100 | 26 | 84 | 27 |
Effect of dilutive stock options | 100 | 26 | 84 | 27 |
Stock Options [Member]
|
||||
Denominator | ||||
Restricted stock outstanding | 15 | 14 | 15 | 13 |
Effect of dilutive stock options | 15 | 14 | 15 | 13 |
Series 2012 Notes [Member]
|
||||
Denominator | ||||
Assumed conversion of debt | 2,252 | 2,189 | ||
Due 2012 [Member]
|
||||
Denominator | ||||
Assumed conversion of debt | 19,743 | 19,743 | ||
Due February 2015 [Member]
|
||||
Denominator | ||||
Assumed conversion of debt | 163 | 26,627 | 921 | 26,627 |
Weighted-average shares used to compute net income per diluted share | 142,213 | 186,060 | 142,890 | 186,055 |
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The after-tax amount of interest recognized in the period associated with any convertible debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net Income or Loss Available to Common Stockholders plus adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 3 - Fair Value Measurements (Detail) - Assets and Liabilities Recorded at Fair Value (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Assets: | ||
Available for Sale Securities at Fair Value | $ 171,895 | $ 224,769 |
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 2 [Member]
|
||
Assets: | ||
Foreign currency hedge contracts | 2,122 | 9,783 |
Derivative Financial Instruments, Liabilities [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Foreign currency hedge contracts | 2,122 | 9,783 |
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 127,068 | 163,368 |
Money Market Funds [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 127,068 | 163,368 |
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 37,314 | 44,877 |
Corporate Debt Securities [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 37,314 | 44,877 |
Commercial Paper [Member] | Fair Value, Inputs, Level 2 [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 8,996 | |
Commercial Paper [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 8,996 | |
US Government Agencies Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 2,008 | 2,015 |
US Government Agencies Debt Securities [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 2,008 | 2,015 |
US Treasury Securities [Member] | Fair Value, Inputs, Level 1 [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 5,505 | 5,513 |
US Treasury Securities [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Available for Sale Securities at Fair Value | 5,505 | 5,513 |
Derivative Financial Instruments, Assets [Member] | Fair Value, Inputs, Level 2 [Member]
|
||
Assets: | ||
Foreign currency hedge contracts | 2,675 | 6,838 |
Derivative Financial Instruments, Assets [Member] | Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Foreign currency hedge contracts | 2,675 | 6,838 |
Fair Value, Inputs, Level 1 [Member]
|
||
Assets: | ||
Total | 134,581 | 170,896 |
Fair Value, Inputs, Level 2 [Member]
|
||
Assets: | ||
Total | 39,989 | 60,711 |
Estimate of Fair Value, Fair Value Disclosure [Member]
|
||
Assets: | ||
Total | $ 174,570 | $ 231,607 |
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents contracts related to the exchange of different currencies, including foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into and existing as of the balance sheet date. No definition available.
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents contracts related to the exchange of different currencies, including foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into and existing as of the balance sheet date. No definition available.
|
Note 3 - Fair Value Measurements (Detail) - Assets and Liabilities Not Recorded at Fair Value (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Assets: | ||
Note receivable | $ 7,435 | |
Note receivable | 7,445 | 0 |
Liabilities: | ||
Carrying Value | 327,505 | 409,985 |
Fair Value | 400,183 | 442,835 |
Series 2012 Notes [Member]
|
||
Liabilities: | ||
Carrying Value | 162,626 | |
Fair Value | 207,193 | |
Convertible May 2015 Notes [Member]
|
||
Liabilities: | ||
Carrying Value | 141,152 | 138,952 |
Fair Value | 168,640 | 156,123 |
Convertible February 2015 Notes [Member]
|
||
Liabilities: | ||
Carrying Value | 989 | 177,663 |
Fair Value | 1,158 | 191,475 |
Non-Recourse Notes [Member]
|
||
Liabilities: | ||
Carrying Value | 22,738 | 93,370 |
Fair Value | $ 23,192 | $ 95,237 |
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. No definition available.
|
X | ||||||||||
- Definition
An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) more than one year from the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. An amount representing an agreement for an unconditional promise by the maker to pay the Company (holder) a definite sum of money at a future date(s). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 4 - Cash Equivalents, Short-term and Long-term Investments (Detail) (USD $)
|
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Dec. 31, 2011
|
|
Available-for-sale Securities, Gross Realized Gain (Loss) | $ 0 | $ 0 | $ 0 | $ 0 | |
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax | 42,000 | 42,000 | 29,000 | ||
Other than Temporary Impairment Losses, Investments | 0 | ||||
Maximum [Member]
|
|||||
Unrealized Loss on Securities | $ 1,000 |
X | ||||||||||
- Definition
Accumulated appreciation or loss, net of tax, in value of the total of available-for-sale securities at the end of an accounting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The increase (decrease), resulting in a loss, in the difference between the fair value and the carrying value, or in the comparative fair values, of securities held at each balance sheet date, that was included in earnings for the period. No definition available.
|
Note 4 - Cash Equivalents, Short-term and Long-term Investments (Detail) - Available-for-Sale Debt Securities (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Amortized Cost | $ 171,831 | $ 224,725 |
Gross Unrealized Gains | 65 | 88 |
Gross Unrealized Losses | (1) | (44) |
Estimated Fair Value | 171,895 | 224,769 |
Money Market Funds [Member]
|
||
Amortized Cost | 127,068 | 163,368 |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | 0 | |
Estimated Fair Value | 127,068 | 163,368 |
Corporate Debt Securities [Member]
|
||
Amortized Cost | 37,263 | 44,863 |
Gross Unrealized Gains | 52 | 57 |
Gross Unrealized Losses | (1) | (43) |
Estimated Fair Value | 37,314 | 44,877 |
Commercial Paper [Member]
|
||
Amortized Cost | 0 | 8,997 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | (1) |
Estimated Fair Value | 0 | 8,996 |
US Government Agencies Debt Securities [Member]
|
||
Amortized Cost | 2,002 | 2,003 |
Gross Unrealized Gains | 6 | 12 |
Gross Unrealized Losses | 0 | 0 |
Estimated Fair Value | 2,008 | 2,015 |
US Treasury Securities [Member]
|
||
Amortized Cost | 5,498 | 5,494 |
Gross Unrealized Gains | 7 | 19 |
Gross Unrealized Losses | 0 | 0 |
Estimated Fair Value | $ 5,505 | $ 5,513 |
X | ||||||||||
- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This item represents the gross unrealized gains for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This item represents the gross unrealized losses for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. No definition available.
|
Note 4 - Cash Equivalents, Short-term and Long-term Investments (Detail) - Available-For-Sale Securities Balance Sheet Classification (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Cash equivalents | $ 127,068 | $ 165,367 |
Short-term investments | 43,812 | 42,301 |
Long-term investments | 1,015 | 17,101 |
Total | $ 171,895 | $ 224,769 |
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Company may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 4 - Cash Equivalents, Short-term and Long-term Investments (Detail) - Summary of Available-For-Sale Securities (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Less than one year | $ 43,754 | $ 44,262 |
Less than one year | 43,812 | 44,300 |
Greater than one year but less than five years | 1,009 | 17,095 |
Greater than one year but less than five years | 1,015 | 17,101 |
Total | 44,763 | 61,357 |
Total | $ 44,827 | $ 61,401 |
X | ||||||||||
- Definition
Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of available-for-sale debt securities at cost, net of adjustments, which include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of debt securities categorized neither as held-to-maturity nor trading. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 5 - Foreign Currency Hedging (Detail) (USD $)
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net | $ (27,000) | |||
Net of Tax [Member]
|
||||
Gain (Loss) on Interest Rate Cash Flow Hedge Ineffectiveness | 57,000 | |||
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months | (800,000) | (800,000) | ||
Forecasted Transactions [Member]
|
||||
Gain (Loss) on Cash Flow Hedge Ineffectiveness, Net | $ 0 | $ 19,000 | $ 0 | $ 19,000 |
X | ||||||||||
- Definition
The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net gain (loss) recognized in earnings during the reporting period representing the amount of the cash flow hedges' ineffectiveness. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The net gain (loss) during the reporting period due to ineffectiveness in interest rate cash flow hedges. Recognized in earnings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 5 - Foreign Currency Hedging (Detail) - Schedule of Foreign Currency Exchange Contracts Designated as Cash Flow Hedges (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Eurodollar Sell Forward Contract 1.400 [Member] | Foreign Exchange Forward [Member]
|
||
Settlement Price ($ per Eurodollar) | 1.400 | |
Notional Amount | $ 25,150 | |
Fair Value | 1,837 | |
Notional Amount | 25,150 | |
Fair Value | 1,837 | |
Eurodollar Sell Forward Contract 1.200 [Member] | Foreign Exchange Forward [Member]
|
||
Settlement Price ($ per Eurodollar) | 1.200 | |
Notional Amount | 117,941 | |
Fair Value | (9,783) | |
Notional Amount | 117,941 | |
Fair Value | (9,783) | |
Eurodollar Sell Foward Contract 1.230 [Member] | Foreign Exchange Forward [Member]
|
||
Settlement Price ($ per Eurodollar) | 1.230 | |
Notional Amount | 85,494 | |
Fair Value | (2,122) | |
Notional Amount | 85,494 | |
Fair Value | (2,122) | |
Eurodollar Sell Foward Contract 1.300 [Member] | Foreign Exchange Forward [Member]
|
||
Settlement Price ($ per Eurodollar) | 1.300 | |
Notional Amount | 128,700 | |
Fair Value | 2,675 | |
Notional Amount | 128,700 | |
Fair Value | 2,675 | |
Eurodollar Purchased Call Option 1.510 [Member] | Foreign Exchange Option [Member]
|
||
Notional Amount | 27,126 | |
Strike Price ($ per Eurodollar) (in Dollars per Item) | 1.510 | |
Notional Amount | 27,126 | |
Eurodollar Purchased Call Option 1.315 [Member] | Foreign Exchange Option [Member]
|
||
Notional Amount | 129,244 | |
Fair Value | 5,001 | |
Strike Price ($ per Eurodollar) (in Dollars per Item) | 1.315 | |
Notional Amount | 129,244 | |
Fair Value | 5,001 | |
Foreign Exchange Forward [Member]
|
||
Notional Amount | 214,194 | 143,091 |
Fair Value | 553 | (7,946) |
Notional Amount | 214,194 | 143,091 |
Fair Value | 553 | (7,946) |
Foreign Exchange Option [Member]
|
||
Notional Amount | 156,370 | |
Fair Value | 5,001 | |
Notional Amount | 156,370 | |
Fair Value | $ 5,001 |
X | ||||||||||
- Definition
The strike price on the foreign currency option contract such as a put option or a call option. No definition available.
|
X | ||||||||||
- Definition
Contractual rate at which a foreign currency can be purchased or sold. No definition available.
|
X | ||||||||||
- Definition
Fair value as of the balance sheet date of all foreign currency derivatives designated as cash flow hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate notional amount of all foreign currency derivatives designated as hedging instruments in cash flow hedges. Notional amount refers to the number of currency units specified in the foreign currency derivative contract. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 5 - Foreign Currency Hedging (Detail) - Fair Value of Foreign Currency Exchange Contracts on Condensed Consolidated Balance Sheet (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Prepaid And Other Current Assets [Member]
|
||
Euro contracts | $ 831 | $ 1,837 |
Other Assets [Member]
|
||
Euro contracts | 1,844 | |
Accrued Liabilities [Member]
|
||
Euro contracts | 2,122 | 4,134 |
Other Long-Term Liabilities [Member]
|
||
Euro contracts | $ 648 |
X | ||||||||||
- Definition
Fair value as of the balance sheet date of all foreign currency derivative assets designated as cash flow hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 5 - Foreign Currency Hedging (Detail) - Derivative Instruments Designated as Cash Flow Hedges Effect on Other Comprehensive Income (Loss) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|||||||||||
Net gain (loss) recognized in OCI, net of tax (1) | $ 7,086 | [1] | $ (1,695) | [1] | $ 1,603 | [1] | $ (8,675) | [1] | ||||||
Gain (loss) reclassified from accumulated OCI into royalty revenue, net of tax (2) | (1,864) | [2] | (218) | [2] | (670) | [2] | 586 | [2] | ||||||
Net gain (loss) recognized in interest and other income, net (3) | 57 | [3] | (19) | [3] | (27) | [3] | (19) | [3] | ||||||
Amount excluded from effectiveness testing | $ 0 | $ 0 | $ 0 | $ 0 | ||||||||||
|
X | ||||||||||
- Definition
The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of net gains and losses recognized in income during the period on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges, on derivative instruments designated and qualifying as hedging instruments in cash flow hedges, and on derivative instruments not designated as hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 6 - Note Receivable (Detail) (USD $)
In Millions, unless otherwise specified |
Mar. 31, 2012
|
---|---|
Financing Receivable, Gross (in Dollars) | $ 7.5 |
Interest Rate on Note Receivable | 10.00% |
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Amount representing an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. Excludes amounts related to receivables held-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 7 - Accrued Liabilities (Detail) - Accrued Liabilities (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Compensation | $ 1,426 | $ 1,341 |
Interest payable | 3,029 | 3,351 |
Deferred revenue | 1,713 | |
Dividend payable | 42,076 | 52 |
Other | 2,353 | 1,018 |
Total | 51,006 | 11,609 |
Accrued Liabilities [Member]
|
||
Foreign currency hedge | $ 2,122 | $ 4,134 |
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Fair value as of the balance sheet date of all foreign currency derivative liabilities designated as cash flow hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 8 - Commitments and Contingencies (Detail) (USD $)
|
6 Months Ended | |||||
---|---|---|---|---|---|---|
Jun. 30, 2012
|
Dec. 31, 2011
|
Jul. 07, 2011
|
Jun. 30, 2012
Europe [Member]
|
Jun. 30, 2012
Past U.S. Based Sales [Member]
|
Jun. 30, 2012
Future U.S. Based Sales [Member]
|
|
RoyaltyRevenueGeographicConcentration | 32.00% | |||||
Gain Contingency, Unrecorded Amount (in Dollars) | $ 1,000,000,000 | |||||
Royalty Rate | 3.75% | 3.75% | ||||
Number of Genentech's Claims Dismissed by Court | 2 | |||||
Number of PDL's Claims Upheld by Court | 4 | |||||
Number of PDL's claims for relief relating to the 2003 settlement agreement | 5 | |||||
Number of PDL's claims dismissed by the court | 1 | |||||
Operating Leases, Future Minimum Payments Due (in Dollars) | 105,600,000 | |||||
Loss Contingency, Estimate of Possible Loss (in Dollars) | $ 10,700,000 | $ 10,700,000 |
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Number of PDL's claims dismissed by the court No definition available.
|
X | ||||||||||
- Definition
Number of PDL's claims for relief relating to the 2003 settlement agreement. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Retroactive royalty rate on past US-based Sales of the Genentech Products and interest, among other items. No definition available.
|
X | ||||||||||
- Definition
Revenues derived from sales of products that were made in US and foreign geographies. No definition available.
|
X | ||||||||||
- Definition
The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Reflects the estimated amount of loss from the specified contingency as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes (Detail) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 18 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
Series 2012 Notes [Member]
Initial [Member]
|
Jun. 30, 2012
Series 2012 Notes [Member]
Minimum [Member]
|
Mar. 31, 2012
Series 2012 Notes [Member]
Minimum [Member]
|
Feb. 29, 2012
Series 2012 Notes [Member]
|
Jun. 30, 2012
Series 2012 Notes [Member]
|
Mar. 31, 2012
Series 2012 Notes [Member]
|
Jun. 30, 2012
Series 2012 Notes [Member]
|
Dec. 31, 2011
Series 2012 Notes [Member]
|
Jun. 30, 2012
Series 2012 Notes [Member]
|
Jan. 31, 2012
Series 2012 Notes [Member]
|
Jun. 30, 2012
Convertible February 2015 Notes [Member]
February 2015 Notes Exchanged For Series 2012 Notes [Member]
|
Jun. 30, 2012
Convertible February 2015 Notes [Member]
|
Jun. 30, 2012
February 2015 Notes Exchanged For Series 2012 Notes [Member]
|
Jun. 30, 2012
Convertible May 2015 Notes [Member]
|
Jun. 30, 2011
Convertible May 2015 Notes [Member]
|
Jun. 30, 2012
Convertible May 2015 Notes [Member]
|
Jun. 30, 2011
Convertible May 2015 Notes [Member]
|
Dec. 31, 2011
Convertible May 2015 Notes [Member]
|
Jun. 30, 2011
Due 2012 [Member]
|
Jun. 30, 2011
Due 2012 [Member]
|
Jun. 30, 2012
Non-Recourse Notes [Member]
|
|
Convertible Debt | $ 169,000,000 | $ 1,000,000 | $ 22,700,000 | |||||||||||||||||||||
Incentive Fee Per Thousand to Convert Debt | 5.00 | |||||||||||||||||||||||
Induced Conversion of Convertible Debt Expense | 845,000 | |||||||||||||||||||||||
Deferred Costs, Noncurrent | 765,000 | 765,000 | 765,000 | |||||||||||||||||||||
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | 52,000 | 10,900,000 | ||||||||||||||||||||||
Noted Obligation Allocated To Deferred Tax Asset | 28,000 | 28,000 | 28,000 | |||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 10,000,000 | |||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.875% | 2.875% | 2.875% | 2.875% | ||||||||||||||||||||
Debt Instrument, Convertible, Conversion Ratio | 155.3960 | 162.8850 | 162.8850 | 142.5217 | ||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 6.44 | $ 7.98 | $ 8.17 | $ 6.14 | $ 6.14 | $ 6.14 | $ 6.14 | $ 7.02 | $ 7.02 | |||||||||||||||
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | 216,000 | 597,000 | 813,000 | |||||||||||||||||||||
Debt Instrument, Convertible, Terms of Conversion Feature | During any fiscal quarter commencing after the fiscal quarter ending December 31, 2011, if the closing price of the Company's common stock for at least 20 trading days in a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter exceeds 130% of the conversion price for the Series 2012 Notes on the last day of such preceding fiscal quarter; During the five business-day period immediately after any five consecutive trading-day period in which the trading price per $1,000 principal amount of the Series 2012 Notes for each trading day of that measurement period was less than 98% of the product of the closing price of the Company's common stock and the conversion rate for the Series 2012 Notes for that trading day; Upon the occurrence of certain corporate transactions as provided in the Indenture; or Anytime, at the holder's option, beginning on August 15, 2014. | |||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 16,374,000 | 16,374,000 | 16,374,000 | 2,300,000 | 11,000 | 16,800,000 | 14,098,000 | 14,098,000 | 16,298,000 | |||||||||||||||
Debt Instrument, Convertible, Effective Interest Rate | 7.30% | |||||||||||||||||||||||
Noted obligation allocated to deferred tax liability | 5,900,000 | |||||||||||||||||||||||
Debt Instrument, Convertible, Remaining Discount Amortization Period | 2 years 219 days | 2 years 219 days | 2 years 292 days | 109 days | ||||||||||||||||||||
Debt Instrument, Fair Value Disclosure | 14,300,000 | 14,300,000 | 14,300,000 | |||||||||||||||||||||
Option Indexed to Issuer's Equity, Shares (in Shares) | 22.1 | |||||||||||||||||||||||
Option Indexed to Issuer's Equity, Strike Price (in Dollars per Item) | 7.02 | |||||||||||||||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares) | 27.5 | 27.5 | ||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item) | 8.25 | 8.25 | ||||||||||||||||||||||
Unamortized Debt Issuance Expense | 15,000 | 100,000 | ||||||||||||||||||||||
Debt Instrument, Increase (Decrease) for Period, Net | 133,500,000 | |||||||||||||||||||||||
Redemption price of face value (in hundredths) | 100.29% | 100.29% | ||||||||||||||||||||||
Aggregate consideration of redemption | 133,900,000 | 133,900,000 | ||||||||||||||||||||||
Debt Instrument, Convertible, Interest Expense | 2,979,000 | 5,878,000 | 2,862,000 | 1,391,000 | 5,703,000 | 1,391,000 | 1,000,000 | |||||||||||||||||
Gains (Losses) on Extinguishment of Debt | $ (766,000) | $ (766,000) | $ (800,000) |
X | ||||||||||
- Definition
Total consideration of repayment including principal, interest and applicable premium. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Adjustment to deferred tax asset resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. No definition available.
|
X | ||||||||||
- Definition
Adjustment to deferred tax liability resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. No definition available.
|
X | ||||||||||
- Definition
Redemption price of face value of notes. No definition available.
|
X | ||||||||||
- Definition
Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The exercise price of each class of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The ratio applied to the debt for purposes of determining the number of shares of the equity security into which the debt will be converted. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The effective interest rate on the liability component of convertible debt instrument which may be settled in cash upon conversion, including partial cash settlement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Interest expense related to convertible debt instruments which has been recognized for the period, including the contractual interest coupon and amortization of the debt discount, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Description of the conversion terms of a debt instrument which may include the conversion ratio (including all potential conversion ratios if contingently adjustable), type of debt or equity security into which the debt is convertible, the dollars of debt or the number of shares into which the instrument is convertible (or potentially convertible into), the conversion period, any contingencies associated with the conversion terms, and the existence and amount of a beneficial conversion feature. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net increase or decrease in the carrying amount of the debt instrument for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Interest rate stated in the contractual debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Sum of the carrying amounts of deferred costs that are expected to be recognized as a charge against earnings in periods after one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The exercise (or strike) price stated in the contract. The fixed price at which the option holder can purchase, in the case of a call option, or sell, in the case of a put option, on the underlying security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes (Detail) - Convertible and Non-recourse Notes Activity (USD $)
In Thousands, unless otherwise specified |
6 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2012
|
Dec. 31, 2011
|
||||
Carrying Value | $ 327,505 | $ 409,985 | |||
Convertible May 2015 Notes [Member]
|
|||||
Maturity Date | May 01, 2015 | ||||
Principal Balance Oustanding June 30, 2012 | 155,250 | 155,250 | |||
Carrying Value | 141,152 | 138,952 | |||
Series 2012 Notes [Member]
|
|||||
Maturity Date | Feb. 15, 2015 | ||||
Principal Balance Oustanding June 30, 2012 | 179,000 | ||||
Carrying Value | 162,626 | ||||
Convertible February 2015 Notes [Member]
|
|||||
Maturity Date | Feb. 15, 2015 | ||||
Principal Balance Oustanding June 30, 2012 | 1,000 | ||||
Carrying Value | 989 | 177,663 | |||
Non-Recourse Notes [Member]
|
|||||
Maturity Date | Sep. 15, 2012 | [1] | |||
Principal Balance Oustanding June 30, 2012 | 22,738 | ||||
Carrying Value | $ 22,738 | $ 93,370 | |||
|
X | ||||||||||
- Definition
The stated principal amount of the debt instrument at time of issuance, which may vary from the carrying amount because of unamortized premium or discount. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes (Detail) - May 2012 Notes (USD $)
|
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Net carrying value of the Series 2012 Notes | $ 327,505,000 | $ 409,985,000 |
Series 2012 Notes [Member]
|
||
Principal amount of the Series 2012 Notes | 179,000,000 | |
Unamortized discount of liability component | (16,374,000) | |
Net carrying value of the Series 2012 Notes | $ 162,626,000 |
X | ||||||||||
- Definition
The stated principal amount of the debt instrument at time of issuance, which may vary from the carrying amount because of unamortized premium or discount. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes (Detail) - Interest Expense For Our Series 2012 Notes (Series 2012 Notes [Member], USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended |
---|---|---|
Jun. 30, 2012
|
Jun. 30, 2012
|
|
Series 2012 Notes [Member]
|
||
Contractual coupon interest | $ 1,287 | $ 2,550 |
Amortization of debt issuance costs | 277 | 548 |
Amortization of debt discount | 1,415 | 2,780 |
Total | $ 2,979 | $ 5,878 |
X | ||||||||||
- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Interest expense related to convertible debt instruments which has been recognized for the period, including the contractual interest coupon and amortization of the debt discount, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes (Detail) - May 2015 Notes (USD $)
|
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Net carrying value of the May 2015 Notes | $ 327,505,000 | $ 409,985,000 |
Convertible May 2015 Notes [Member]
|
||
Principal amount of the May 2015 Notes | 155,250,000 | 155,250,000 |
Unamortized discount of liability component | (14,098,000) | (16,298,000) |
Net carrying value of the May 2015 Notes | $ 141,152,000 | $ 138,952,000 |
X | ||||||||||
- Definition
The stated principal amount of the debt instrument at time of issuance, which may vary from the carrying amount because of unamortized premium or discount. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 9 - Convertible Notes and Non-recourse Notes (Detail) - Interest Expense for our May 2015 Notes (Convertible May 2015 Notes [Member], USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Convertible May 2015 Notes [Member]
|
||||
Contractual coupon interest | $ 1,455 | $ 728 | $ 2,911 | $ 728 |
Amortization of debt issuance costs | 297 | 144 | 592 | 144 |
Amortization of debt discount | 1,110 | 519 | 2,200 | 519 |
Total | $ 2,862 | $ 1,391 | $ 5,703 | $ 1,391 |
X | ||||||||||
- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Interest expense related to convertible debt instruments which has been recognized for the period, including the contractual interest coupon and amortization of the debt discount, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 10 - Other Long-Term Liabilities (Detail) - Other Long-term Liabilities (USD $)
In Thousands, unless otherwise specified |
Jun. 30, 2012
|
Dec. 31, 2011
|
---|---|---|
Accrued lease liability | $ 10,700 | $ 10,700 |
Uncertain tax position | 12,761 | 12,774 |
Compensation | 228 | |
Foreign currency hedge | 648 | |
Total | $ 23,689 | $ 24,122 |
X | ||||||||||
- Definition
Employee related liabilities noncurrent. No definition available.
|
X | ||||||||||
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer) for contractual rent under lease arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Fair value of derivative liability, presented on a gross basis even when the derivative instrument is subject to master netting arrangements and qualifies for net presentation in the statement of financial position. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 11 - Stock-Based Compensation (Detail) (Restricted Stock [Member])
|
15 Months Ended | 21 Months Ended | 1 Months Ended | 15 Months Ended | 3 Months Ended | |||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
June 2013 [Member]
|
Dec. 31, 2013
December 2013 [Member]
|
Dec. 31, 2011
December 2011 [Member]
|
Jun. 30, 2012
June 2012 [Member]
|
Jun. 30, 2012
December 2012 [Member]
|
Jun. 30, 2012
|
Mar. 31, 2012
|
Jun. 30, 2011
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | 32,000 | 24,000 | 34,000 | 63,000 | 56,000 | 59,000 | 115,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 18,000 |
X | ||||||||||
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 11 - Stock-Based Compensation (Detail) - Stock-Based Compensation (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Share based compensation | $ 232 | $ 74 | $ 436 | $ 124 |
Directors and Employees [Member]
|
||||
Share based compensation | 177 | 74 | 327 | 124 |
Non-Employees [Member]
|
||||
Share based compensation | $ 55 | $ 109 |
X | ||||||||||
- Definition
The amount of expense, net of income tax, recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. No definition available.
|
Note 12 - Cash Dividends (Detail) (USD $)
|
Jun. 30, 2012
|
Jan. 18, 2012
|
---|---|---|
Dividends Payable, Amount Per Share (in Dollars per share) | $ 0.15 | |
Dividends Payable Dates To be Paid Day Month And Year | March14, June14,September14 and December14 of 2012 | |
Dividends Payable Dates of Record, Day, Month and Year | March7, June7,September7 and December 7 of 2012 |
X | ||||||||||
- Definition
Declaration of date(s) as of when a holder must own the stock to be entitled to the dividend. The ex-dividend date is generally 3 days before the record date. No definition available.
|
X | ||||||||||
- Definition
For declared dividends, day, month, and year (YYYY-MM-DD) that the dividend declared as of or prior to the financial reporting date will be paid in the subsequent period. No definition available.
|
X | ||||||||||
- Definition
The per share amount of a dividend declared, but not paid, as of the financial reporting date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 12 - Cash Dividends (Detail) - Conversion Rates for Convertible Notes (USD $)
|
6 Months Ended |
---|---|
Jun. 30, 2012
|
|
Convertible May 2015 Notes [Member]
|
|
Conversion Rate per $1,000 Principal Amount | 142.5217 |
Approximate Conversion Price Per Common Share (in Dollars per share) | $ 7.02 |
Effective Date | Jun. 05, 2012 |
Series 2012 Notes [Member]
|
|
Conversion Rate per $1,000 Principal Amount | 162.885 |
Approximate Conversion Price Per Common Share (in Dollars per share) | $ 6.14 |
Effective Date | Jun. 05, 2012 |
Convertible February 2015 Notes [Member]
|
|
Conversion Rate per $1,000 Principal Amount | 162.885 |
Approximate Conversion Price Per Common Share (in Dollars per share) | $ 6.14 |
Effective Date | Jun. 08, 2012 |
X | ||||||||||
- Definition
The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The ratio applied to the debt for purposes of determining the number of shares of the equity security into which the debt will be converted. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Earliest date when the debt instrument can be converted into equity, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 13 - Income Taxes (Detail)
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate | 35.00% | 35.00% | 35.00% | 35.00% |
X | ||||||||||
- Definition
The domestic federal statutory tax rate applicable under enacted tax laws to the Company's pretax income from continuing operations for the period. The "statutory" tax rate is the regular tax rate if there are alternative tax systems. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 13 - Income Taxes (Detail) - Income Taxes (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Income Tax | $ 39,813 | $ 37,976 | $ 61,417 | $ 62,009 |
X | ||||||||||
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 14 - Accumulated Comprehensive Loss (Detail) - Accumulated Other Comprehensive Income (Loss), Net of Tax (USD $)
|
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2012
|
Jun. 30, 2011
|
|
Beginning Balance at December 31, 2011 | $ 29,000 | |||
Beginning Balance at December 31, 2011 | (1,914,000) | |||
Beginning Balance at December 31, 2011 | (1,885,000) | |||
Activity for the six months ended June 30, 2012 | (16,000) | 71,000 | 13,000 | 47,000 |
Activity for the six months ended June 30, 2012 | 8,950,000 | (1,478,000) | 2,273,000 | (9,261,000) |
Activity for the six months ended June 30, 2012 | 8,934,000 | (1,407,000) | 2,286,000 | (9,214,000) |
Ending Balance at June 30, 2012 | 42,000 | 42,000 | ||
Ending Balance at June 30, 2012 | 359,000 | 359,000 | ||
Ending Balance at June 30, 2012 | $ 401,000 | $ 401,000 |
X | ||||||||||
- Definition
Accumulated appreciation or loss, net of tax, in value of the total of available-for-sale securities at the end of an accounting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net of tax amount of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net of tax amount, before reclassification adjustments, of the change in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Also includes an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net of tax amount of unrealized holding gain (loss) before reclassification adjustments and transfers on available-for-sale securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
Note 15. Subsequent Event (Detail) (USD $)
In Millions, unless otherwise specified |
0 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Jul. 10, 2012
|
Jul. 11, 2013
|
Mar. 31, 2012
|
Jul. 13, 2012
Additional Loan [Member]
Merus Labs International Inc. [Member]
|
Jul. 11, 2012
Additional Loan [Member]
Merus Labs International Inc. [Member]
|
Jul. 11, 2012
Initial Loan [Member]
Merus Labs International Inc. [Member]
|
Jul. 10, 2012
Merus Labs International Inc. [Member]
|
Jul. 13, 2012
Merus Labs International Inc. [Member]
|
|
Financing Receivable, Gross | $ 7.5 | $ 35.0 | ||||||
Letter of Credit Extended | 20 | |||||||
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred | $ 20 | |||||||
Date of Remaining Purchase Price Obligation | Jul. 11, 2013 | |||||||
Interest Rate on Note Receivable | 10.00% | 14.00% | 13.50% | |||||
Loans and Leases Receivable, Other Information | March 31, 2015 |
X | ||||||||||
- Definition
Date of remaining purchase price obligation. No definition available.
|
X | ||||||||||
- Definition
No authoritative reference available. No definition available.
|
X | ||||||||||
- Definition
Letter of credit extended. No definition available.
|
X | ||||||||||
- Definition
Fair Value of the liabilities incurred by the acquirer to former owners of the acquiree, including the fair value of any contingent consideration. If liabilities transferred as consideration remain within the combined entity after the business combination (for example, because the assets or liabilities were transferred to the acquiree rather than to its former owners), and the acquirer therefore retains control of them; in that situation, the acquirer measures those liabilities at their carrying amounts immediately before the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Describes matters pertaining to loans not reflected elsewhere. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount representing an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. Excludes amounts related to receivables held-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|